Ftse Mib
35.143,06
-0,49%
DAX
20.214,79
-0,51%
S&P 500
5.842,16
-1,29%
NASDAQ
19.207,77
-1,39%
Bitcoin
95.300,00
3,12%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Precision BioSciences Inc (DTIL) Precision BioSciences Inc (DTIL) Notizie

Precision BioSciences Inc

DTIL
5,56
1,06 (23,56%)
Ultimo aggiornamento: 20:49:14
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/1/202516:01BWPrecision BioSciences Announces Complete Clinical Response..
09/1/202514:00BWiECURE Reports Complete Clinical Response in First Infant..
08/1/202514:05EDGAR2Form 8-K - Current report
02/1/202513:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/12/202413:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/12/202413:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202412:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202413:01BWPrecision BioSciences Receives Approval in Hong Kong to..
21/11/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202413:01BWPrecision BioSciences to Participate in Upcoming November..
15/11/202413:00BWPrecision BioSciences Highlights Preclinical Data and..
06/11/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202421:51EDGAR2Form 144 - Report of proposed sale of securities
04/11/202421:49EDGAR2Form 144 - Report of proposed sale of securities
04/11/202413:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/11/202413:15EDGAR2Form 8-K - Current report
04/11/202413:01BWPrecision BioSciences Reports Third Quarter 2024 Financial..
29/10/202412:01BWPrecision BioSciences to Report Third Quarter Results on..
28/10/202412:01BWPrecision BioSciences to Host Virtual Investor Event..
24/10/202422:15BWPrecision BioSciences Presents Preclinical Data Highlighting..
24/10/202414:47BWPrecision BioSciences Receives First Approval of Clinical..
24/10/202414:45EDGAR2Form 8-K - Current report
21/10/202413:01BWPrecision BioSciences to Participate in Upcoming Longwood..
16/10/202413:01BWPrecision BioSciences to Present at the European Society of..
03/10/202413:01BWPrecision BioSciences to Present at the Upcoming H.C...
30/9/202413:01BWPrecision BioSciences Submits First Clinical Trial..
20/9/202413:01BWPrecision BioSciences Announces Grant of Inducement Awards..
12/9/202414:00EDGAR2Form 8-K - Current report
12/9/202413:15BWPrecision BioSciences Strengthens Senior Leadership Team..
04/9/202413:01BWPrecision BioSciences to Participate in Upcoming H.C...
03/9/202414:03EDGAR2Form 8-K - Current report
03/9/202413:01BWPrecision BioSciences Receives $13 Million in Proceeds from..
23/8/202413:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202413:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202413:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202413:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202413:01BWPrecision BioSciences Announces Investigational New Drug..
01/8/202413:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202413:30EDGAR2Form 8-K - Current report
01/8/202413:15BWPrecision BioSciences Reports Second Quarter 2024 Financial..
31/7/202413:01BWPrecision BioSciences to Participate in Upcoming August..
29/7/202422:15BWPrecision BioSciences to Report Second Quarter Results on..
08/7/202413:01BWPrecision BioSciences to Present at the Upcoming..
01/7/202413:01BWPrecision BioSciences Announces its Addition to the Russell..
27/6/202413:01BWPrecision BioSciences Announces Presentation at UMDF..
20/6/202413:00BWPrecision BioSciences Expands Hepatitis Scientific Advisory..
11/6/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 6,80 Min: 5,27 Max: 7,4399
Chiusura: 4,50

La tua Cronologia

NASDAQ
DTIL
Precision BioSciences
BIT
UC4ZGV
Unicredit Bank
BIT
S28915
Societe Generale Effekten
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network